[Development of personalized peptide vaccines for advanced cancer patients].
Yamada
Akira
A
D000951:Antigens, Neoplasm / Q000276:immunology; D019496:Cancer Vaccines / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D015234:HLA-A Antigens; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology; D009369:Neoplasms / Q000175:diagnosis / Q000276:immunology / Q000628:therapy*; D010597:Pharmacogenetics; D022223:Vaccines, Subunit / Q000009:adverse effects / Q000627:therapeutic use
D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D015234:HLA-A Antigens; D022223:Vaccines, Subunit